Adding complexity to the idea that non-coding mutations can impact MYB binding sites and contribute to cancer, mutations in a cis-acting element in an intron of the WT1 gene were found to destroy MYB binding and downregulate the tumor suppressor gene WT1 in acute promyelocytic leukemia [42]. Here, MYB is linked to cancer.